Cultivate cells that outperform conventional methods by using optimized membranes and designs for superior density, yield, and efficiency.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
XDemics is advancing cell culture technology by enabling much higher-density cell growth through its patented High Density Cell Respiration system, which integrates gas-permeable membranes and optimized geometry to drastically boost yield, reduce hands-on time, and lower costs. It serves both research labs and industrial production settings, offering scalable solutions from small assay plates up to large bioreactors to make cell-based therapies, biologics, and other cell-derived products more accessible.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
XDemics Management Team
XDemics Valuations & Financials
View real-time NPM data on XDemics stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like XDemics
Redwood Materials
Materials
Closed-loop domestic supply chain for lithium-ion batteries.
KoBold Metals
Materials
Utilizes AI to discover materials used in EVs and other renewable energy applications.
Resilience
Materials
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Solugen
Materials
Manufactures biobased solutions that replace chemicals traditionally made using petroleum or natural gas.
Pivot Bio
Materials
Agricultural technology company developing sustainable nitrogen solutions to reduce synthetic fertilizer use and improve crop production efficiency.
Biomason
Materials
Develops sustainable biocement using biotechnology and natural processes to create eco-friendly concrete alternatives that reduce carbon emissions.
ProGro Bio
Materials
Develops an organic microbial soil inoculant that enhances soil health and boosts crop yields through improved nutrient uptake and root development.
Group14 Technologies
Materials
Develops silicon-carbon composite materials to improve rechargeable battery performance and charging speed for vehicles and electronics.
FAQ
We have answers
XDemics stock does not trade on public stock exchanges. XDemics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in XDemics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
XDemics Stock does not trade on public stock exchanges. In order to sell XDemics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
XDemics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view XDemics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for XDemics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell XDemics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in XDemics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
XDemics is a private company and has not had an IPO. There is currently no XDemics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to XDemics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
